ibuprofen 5% gel
galpharm international ltd - ibuprofen - cutaneous gel - 50mg/1gram
bicalutamide 50mg tablets
a a h pharmaceuticals ltd - bicalutamide - oral tablet - 50mg
targaxan 550mg tablets
norgine pharmaceuticals ltd - rifaximin - oral tablet - 550mg
mirtazapine 15mg orodispersible tablets
de pharmaceuticals - mirtazapine - orodispersible tablet - 15mg
mirtazapine 30mg orodispersible tablets
de pharmaceuticals - mirtazapine - orodispersible tablet - 30mg
daptomycin melita pharm 350mg powder for solution for injection or infusion
melita pharm, s.l. c/roma, 6-10, 08023 - barcelona,, spain - daptomycin - powder for solution for injection/infusion - daptomycin 350 mg - antibacterials for systemic use
daptomycin melita pharm 500mg powder for solution for injection or infusion
melita pharm, s.l. c/roma, 6-10, 08023 - barcelona,, spain - daptomycin - powder for solution for injection/infusion - daptomycin 500 mg - antibacterials for systemic use
ibiamox amoxicillin 1g (as sodium) powder for injection vial
juno pharmaceuticals pty ltd - amoxicillin, quantity: 1 g - injection, powder for - excipient ingredients: - ibiamox is intended for use where the patient?s condition precludes the administration of the oral form of amoxicillin. it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms.,note: therapy should be guided by bacteriological studies, including sensitivity tests, and clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxicillin sodium may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results.,septicaemia: (bacterial) h. influenzae; e. coli (see section 5.1 pharmacodynamic properties - microbiology); p. mirabilis; streptococcus; strep. pneumoniae; strep. faecalis and salmonella typhi.,skin and skin structure: staphylococcus (non-penicillinase-producing), streptococcus; e. coli (see section 5.1 pharmacodynamic properties - microbiology).,respiratory, acute and chronic: h. influenzae; streptococcus; strep. pneumoniae; staphylococcus (non-penicillinase producing); e. coli (see section 5.1 pharmacodynamic properties - microbiology).,genitourinary tract (complicated and uncomplicated), acute and chronic: e. coli (see section 5.1 pharmacodynamic properties - microbiology); p. mirabilis and strep. faecalis.,gonorrhoea: n. gonorrhoeae (nonpenicillinase producing),prophylaxis of endocarditis: amoxicillin sodium may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with prosthetic heart valves or those who have previously had endocarditis.
irinotecan qilu pharma spain 20 mg/ml inf. sol. (conc.) i.v. vial
qilu pharma spain s.l. - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan
irinotecan qilu pharma spain 20 mg/ml inf. sol. (conc.) i.v. vial
qilu pharma spain s.l. - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan